Evidence map›Paper›PMID 41273692›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2026

The Comet Assay in Human Biomonitoring.

Mojgan Najafzadeh, Diana Anderson, Alok Dhawan, Julian Laubenthal

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mojgan NajafzadehFaculty of Life Sciences, School of Chemistry and Biosciences, University of Bradford, Bradford, UK. m.najafzadeh1@bradford.ac.uk.
Diana AndersonMedical Sciences Division, School of Life Sciences, University of Bradford, Bradford, UK.
Alok DhawanCentre of BioMedical Research, Lucknow, Uttar Pradesh, India.
Julian LaubenthalSana HANSE-Klinikum Wismar, Clinic for Psychiatry, Wismar, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human biomonitoring studies aim to identify potential exposures to environmental, occupational, or lifestyle toxicants in human populations and are commonly used by public health decision-makers to predict disease risk. The Comet assay measures changes in genomic stability and is one of the most reliable biomarkers to indicate early biological effects, and therefore is accepted by various governmental regulatory agencies. The appeal of the Comet Assay lies in its relative simplicity, rapidity, sensitivity, and economic efficiency. Furthermore, the assay is known for its broad versatility, as it can be applied to virtually any human cell and easily adapted in order to detect particular biomarkers of interest, such as DNA repair capacity or single- and double-strand breaks. In a standard experiment, isolated single cells are first embedded in agarose and then lysed in high-salt solutions in order to remove all cellular contents except the DNA attached to a nuclear scaffold. Subsequent electrophoresis results in the accumulation of undamaged DNA sequences at the proximity of the nuclear scaffold, while damaged sequences migrate toward the anode. When visualized with fluorochromes, these migrated DNA fragments resemble a Comet tail and can be quantified for their intensity and shape according to internationally drafted guidelines.

Indexed as

Biological MonitoringComet AssayBiomarkersDNA DamageHumansBiomarkersAlkali-labile sitesComet assayDNA damageDouble-strand breaksSingle-cell electrophoresisSingle-strand breaks

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.